To what extent is transgenic technology beneficial to human beings?

Shunfan Yang

doi:10.54254/3029-0821/2/2024011

Research Article

Open access

Published on 9 September 2024

Download pdf

Yang,S. (2024). To what extent is transgenic technology beneficial to human beings?. Journal of Food Science, Nutrition and Health,2,23-30.

Export citation

To what extent is transgenic technology beneficial to human beings?

Shunfan Yang *^,1,

¹ Changsha Changjun High School

* Author to whom correspondence should be addressed.

https://doi.org/10.54254/3029-0821/2/2024011

Abstract

Genetic engineering is a field which explores the possibility of modification or manipulation of genetic materials using various techniques and technologies. Broadly speaking, hybridisation, gene isolation and recombination, fall in this field. The most recent milestone development in this area would be CRISPR technology, which harnesses a component of the bacterial immune system. To elaborate, CRISPR acts as a precise molecular scissors to cut target sequences, thus allowing gene modification to take place. In the progression and advancement of this field, society has been carefully observing its consequences and impact. The utilisation of this technology has raised concerns such as the unknown detrimental impact of genetically modified food sources. On the other hand, the benefit of genetic engineering is self-evident. This article explores the various impacts of genetic engineering and concludes that the advantages of genetic engineering are overshadowed by its many benefits.

Keywords

transgenic technology, genetic engineering, DNA, CRISPR engineering

View pdf

References

[1]. Clark, J. and Whitelaw, B. (2003). A future for transgenic livestock. Nature Reviews Genetics, 4(10), pp.825–833. doi:https://doi.org/10.1038/nrg1183.

[2]. Elder, G.A., Gama Sosa, M.A. and De Gasperi, R. (2010). Transgenic Mouse Models of Alzheimer’s Disease. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 77(1), pp.69–81. doi:https://doi.org/10.1002/msj.20159.

[3]. Ewa, W.-G., Agata, T., Milica, P., Anna, B., Dennis, E., Nick, V., Godelieve, G., Selim, C., Naghmeh, A. and Tomasz, T. (2022). Public perception of plant gene technologies worldwide in the light of food security. GM Crops & Food, 13(1), pp.218–241. doi:https://doi.org/10.1080/21645698.2022.2111946.

[4]. Fan, C., Wu, Y., Rui, X., Yang, Y., Ling, C., Liu, S., Liu, S. and Wang, Y. (2022). Animal models for COVID-19: advances, gaps and perspectives. Signal Transduction and Targeted Therapy, [online] 7, p.220. doi:https://doi.org/10.1038/s41392-022-01087-8.

[5]. Flores, H.A. and O’Neill, S.L. (2018). Controlling vector-borne diseases by releasing modified mosquitoes. Nature Reviews Microbiology, 16(8), pp.508–518. doi:https://doi.org/10.1038/s41579- 018-0025-0.

[6]. Gurumurthy, C.B., Quadros, R.M., Richardson, G.P., Poluektova, L.Y., Mansour, S.L. and Ohtsuka, M. (2020). Genetically modified mouse models to help fight COVID-19. Nature Protocols, [online] 15(12), pp.3777–3787. doi:https://doi.org/10.1038/s41596-020-00403-2.

[7]. Hwang, H.-G., Kim, K.-J., Lee, S.-H., Kim, C.-K., Min, C.-K., Yun, J.-M., Lee, S.U. and Son, Y.-J. (2016). Recombinant Glargine Insulin Production Process Using Escherichia coli. Journal of Microbiology and Biotechnology, 26(10), pp.1781–1789. doi:https://doi.org/10.4014/jmb.1602.02053.

[8]. Kaminski, M.M., Abudayyeh, O.O., Gootenberg, J.S., Zhang, F. and Collins, J.J. (2021). CRISPR- based diagnostics. Nature Biomedical Engineering, 5(7), pp.643–656. doi:https://doi.org/10.1038/s41551-021-00760-7.

[9]. Kato, G.J., Piel, F.B., Reid, C.D., Gaston, M.H., Ohene-Frempong, K., Krishnamurti, L., Smith, W.R., Panepinto, J.A., Weatherall, D.J., Costa, F.F. and Vichinsky, E.P. (2018). Sickle cell disease. Nature Reviews Disease Primers, [online] 4(1). doi:https://doi.org/10.1038/nrdp.2018.10.

[10]. Kornberg, A. (n.d.). The Nobel Prize in Physiology or Medicine 1959. [online] NobelPrize.org. Available at: https://www.nobelprize.org/prizes/medicine/1959/kornberg/facts/ [Accessed 8 Sep. 2023].

[11]. Mah, A. and Roberts, R. (2022). Synthego | Full Stack Genome Engineering. [online] www.synthego.com. Available at: https://www.synthego.com/blog/genome-editing-techniques#7..

[12]. Offord, C. (2018). US Companies Launch CRISPR Clinical Trial. [online] The Scientist Magazine®. Available at: https://www.the-scientist.com/news-opinion/us-companies-launch-crispr- clinical-trial-64746.

[13]. Paine, J.A., Shipton, C.A., Chaggar, S., Howells, R.M., Kennedy, M.J., Vernon, G., Wright, S.Y., Hinchliffe, E., Adams, J.L., Silverstone, A.L. and Drake, R. (2005). Improving the nutritional value of Golden Rice through increased pro-vitamin A content. Nature Biotechnology, [online] 23(4), pp.482–487. doi:https://doi.org/10.1038/nbt1082.

[14]. Parkins, K. (2021). FDA approves first trial investigating CRISPR gene editing as HIV cure. [online] www.clinicaltrialsarena.com. Available at: https://www.clinicaltrialsarena.com/news/crispr-gene-editing-hiv-cure/.

[15]. Petrov, G., Dymova, M. and Richter, V. (2022). Bacteriophage-Mediated Cancer Gene Therapy. International Journal of Molecular Sciences, [online] 23(22), p.14245. doi:https://doi.org/10.3390/ijms232214245.

[16]. Phillips, T. (2014). Genetically Modified Organisms (GMOs) | Learn Science at Scitable. [online] Nature.com. Available at: https://www.nature.com/scitable/topicpage/genetically-modified- organisms-gmos-transgenic-crops-and-732.

[17]. Roberts, R. (2022). Synthego | Full Stack Genome Engineering. [online] www.synthego.com. Available at: https://www.synthego.com/blog/crispr-infectious-disease. [Accessed 11 Dec. 2023].

[18]. Synthego (2023). CRISPR: Gene editing and beyond. [online] www.youtube.com. Available at: http://www.youtube.com/watch?v=4YKFw2KZA5o [Accessed 28 Aug. 2023].

[19]. The Nobel Prize Organization (2020). The Nobel Prize in Chemistry 2020. [online] NobelPrize.org. Available at: http://www.nobelprize.org/prizes/chemistry/2020/161307-press-release-swedish/.

[20]. USDA Foreign Agricultural Service. (2022). China: Agriculture GMOs Safety Assessment Administrative Measures Finalized. [online] Available at: https://www.fas.usda.gov/data/china- agriculture-gmos-safety-assessment-administrative-measures-finalized [Accessed 28 Aug. 2023].

[21]. Wheeler, M.B. (2013). Transgenic Animals in Agriculture | Learn Science at Scitable. [online] www.nature.com. Available at: https://www.nature.com/scitable/knowledge/library/transgenic-animals-in-agriculture-105646080/#:~:text=The%20production%20of%20transgenic%20livestock..

[22]. Wiener-Bronner, D. (2023). Meat without slaughter: Here’s everything you need to know about lab-grown meat | CNN Business. [online] CNN. Available at: https://edition.cnn.com/2023/06/23/business/lab-grown-meat-explainer/index.html [Accessed 23 Sep. 2023].

[23]. Zimmermann, R. and Qaim, M. (2004). Potential health benefits of Golden Rice: a Philippine case study. Food Policy, [online] 29(2), pp.147–168. doi:https://doi.org/10.1016/j.foodpol.2004.03.001.

Cite this article

Yang,S. (2024). To what extent is transgenic technology beneficial to human beings?. Journal of Food Science, Nutrition and Health,2,23-30.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About volume

Journal：Journal of Food Science, Nutrition and Health

Volume number: Vol.2

ISSN：3029-0821(Print) / 3029-083X(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).